SUJIT SANSGIRY to Cost-Benefit Analysis
This is a "connection" page, showing publications SUJIT SANSGIRY has written about Cost-Benefit Analysis.
Connection Strength
0.273
-
Cost effectiveness of thromboprophylaxis with a low-molecular-weight heparin versus unfractionated heparin in acutely ill medical inpatients. Am J Manag Care. 2005 Mar; 11(3):134.
Score: 0.202
-
Impact of changes in reimbursement policies and institutional practice algorithm for utilization of erythropoietic-stimulating agents on treatment patterns and costs in anemic lymphoma patients. Support Care Cancer. 2010 Feb; 19(2):251-9.
Score: 0.071